Financials

  • Market Capitalization 10.25 M
  • Employee 18
  • Founded 2016
  • CEO N/A
  • Website www.in8bio.com
  • Headquarter Delaware, United States
  • FIGI BBG00XX9K1M2
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.53
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4758
GDTC
CytoMed Therapeutics Limited - Ordinary Shares
0.92 USD-3.16%-8.00%+1.10%-54.23%10.88 M USD
4763
APRE
Aprea Therapeutics, Inc. - Common Stock
0.84 USD-2.33%+20.00%+37.70%-46.50%10.58 M USD
4786
FBLG
FibroBiologics, Inc. - Common Stock
1.44 USD-3.36%0.00%+121.54%+144.07%9.59 M USD
4795
XBIO
Xenetic Biosciences, Inc. - Common Stock
3.98 USD+0.25%+6.42%+63.11%+38.68%9.33 M USD

Noticias